Join the Anemia group to help and get support from people like you.
Anemia News
Liberal Transfusion Strategy Not Beneficial for Patients With TBI, Anemia
MONDAY, July 1, 2024 – A liberal transfusion strategy does not reduce the risk of unfavorable neurologic outcome at six months among critically ill patients with traumatic brain injury and anemia,...
Iptacopan Improves Hematologic, Clinical Outcomes in Persistent Anemia
TUESDAY, March 19, 2024 – The first-in-class oral factor B inhibitor iptacopan improves hematologic and clinical outcomes in anti-C5-treated patients with persistent anemia and in those who have not...
AHA: No Real Benefit Seen for Liberal Transfusion Strategy in AMI, Anemia
TUESDAY, Nov. 14, 2023 – For patients with acute myocardial infarction and anemia, a liberal transfusion strategy does not significantly reduce the risk for recurrent myocardial infarction or death...
Testosterone Efficacious for Correcting Anemia in Middle-Aged Men
MONDAY, Oct. 30, 2023 – Testosterone replacement therapy (TRT) is efficacious for correcting anemia among middle-aged and older men with hypogonadism and anemia, according to a study published...
Small-Volume Blood Collection Tubes Could Cut RBC Transfusions
MONDAY, Oct. 16, 2023 – Use of small-volume blood collection tubes in the intensive care unit (ICU) may decrease red blood cell (RBC) transfusions, according to a study published online Oct. 12 in...
Direct Dispensing of Prenatal Supplements With Iron Reduces Anemia
WEDNESDAY, Sept. 27, 2023 – Directly providing prenatal iron supplements significantly improves average hematocrit levels throughout pregnancy and reduces anemia in underserved patients, according...
FDA Approves Ojjaara (momelotinib) for Myelofibrosis Patients with Anemia
Approval is for use in myelofibrosis patients with anemia regardless of prior myelofibrosis therapy Nearly all myelofibrosis patients are estimated to develop anemia over the course of the disease,...
Hypertension, Anemia Contribute to Racial Disparities in Severe Maternal Morbidity
FRIDAY, Sept. 8, 2023 – Hypertension and anemia contribute to racial disparities in severe maternal morbidity (SMM), according to two studies published online Sept. 7 in Obstetrics & Gynecology....
U.S. FDA Approves Bristol Myers Squibb’s Reblozyl (luspatercept-aamt) as First-Line Treatment of Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (MDS) Who May Require Transfusions
PRINCETON, N.J.--(BUSINESS WIRE) August 28, 2023-- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved Reblozyl (luspatercept-aamt) for the...
Anemia Remains Considerable Global Health Challenge
THURSDAY, Aug. 10, 2023 – Anemia remains a considerable global health challenge, according to a study published online July 31 in The Lancet Haematology. William M. Gardener, M.P.H., from the...
FDA Approves Retacrit (epoetin alfa-epbx) as First Epoetin Alfa Biosimilar for the Treatment of Anemia
May 15, 2018 – The U.S. Food and Drug Administration today approved Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia caused by chronic kidney...
Ask a question
To post your own question to this support group, sign in or create an account.